NO20030868L - N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid - Google Patents

N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid

Info

Publication number
NO20030868L
NO20030868L NO20030868A NO20030868A NO20030868L NO 20030868 L NO20030868 L NO 20030868L NO 20030868 A NO20030868 A NO 20030868A NO 20030868 A NO20030868 A NO 20030868A NO 20030868 L NO20030868 L NO 20030868L
Authority
NO
Norway
Prior art keywords
benzenesulfonamide
piperazin
methoxyphenyl
dichloro
methoxy
Prior art date
Application number
NO20030868A
Other languages
English (en)
Other versions
NO20030868D0 (no
Inventor
Steven Mark Bromidge
Stephen Frederick Moss
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20030868D0 publication Critical patent/NO20030868D0/no
Publication of NO20030868L publication Critical patent/NO20030868L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20030868A 2000-08-31 2003-02-25 N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid NO20030868L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021450.2A GB0021450D0 (en) 2000-08-31 2000-08-31 Novel compounds
PCT/EP2001/009927 WO2002018358A1 (en) 2000-08-31 2001-08-27 N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide

Publications (2)

Publication Number Publication Date
NO20030868D0 NO20030868D0 (no) 2003-02-25
NO20030868L true NO20030868L (no) 2003-04-04

Family

ID=9898634

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030868A NO20030868L (no) 2000-08-31 2003-02-25 N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid

Country Status (16)

Country Link
US (1) US20040034036A1 (no)
EP (1) EP1313720A1 (no)
JP (1) JP2004507530A (no)
KR (1) KR20030024919A (no)
CN (1) CN1449391A (no)
AU (1) AU2001284041A1 (no)
BR (1) BR0113650A (no)
CA (1) CA2420935A1 (no)
CZ (1) CZ2003579A3 (no)
GB (1) GB0021450D0 (no)
HU (1) HUP0300863A2 (no)
IL (1) IL154675A0 (no)
MX (1) MXPA03001783A (no)
NO (1) NO20030868L (no)
PL (1) PL361300A1 (no)
WO (1) WO2002018358A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204720D0 (en) * 2002-02-28 2002-04-17 Glaxo Group Ltd Novel use
ATE398108T1 (de) * 2002-03-27 2008-07-15 Glaxo Group Ltd Chinolinderivate und deren verwendung als 5-ht6 liganden
CN101875961B (zh) 2003-07-22 2015-01-07 艾尼纳制药公司 用于预防和治疗相关病症而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物
EP1976495A2 (en) * 2006-01-06 2008-10-08 Aarhus Universitet Compounds acting on the serotonin transporter
EP2120950B1 (en) * 2007-03-21 2012-07-04 Glaxo Group Limited Use of quinoline derivatives in the treatment of pain
EP2508177A1 (en) 2007-12-12 2012-10-10 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
US9840482B2 (en) 2014-04-19 2017-12-12 Sunshine Lake Pharma Co., Ltd. Sulfonamide derivatives and pharmaceutical applications thereof
AU2016276966A1 (en) 2015-06-12 2018-01-18 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of REM sleep behavior disorder
JP2018520187A (ja) 2015-07-15 2018-07-26 アクソヴァント サイエンシーズ ゲゼルシャフト ミット ベシュレンクテル ハフツングAxovant Sciences GmbH 神経変性疾患と関連する幻覚の予防および処置のために有用な5−ht2aセロトニン受容体のモジュレーターとしてのジアリールおよびアリールヘテロアリール尿素誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316450B1 (en) * 1997-07-11 2001-11-13 Smithkline Beecham P.L.C. Compounds
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
NO20030868D0 (no) 2003-02-25
CZ2003579A3 (cs) 2003-09-17
EP1313720A1 (en) 2003-05-28
KR20030024919A (ko) 2003-03-26
CN1449391A (zh) 2003-10-15
JP2004507530A (ja) 2004-03-11
MXPA03001783A (es) 2003-06-04
HUP0300863A2 (hu) 2003-09-29
CA2420935A1 (en) 2002-03-07
IL154675A0 (en) 2003-09-17
GB0021450D0 (en) 2000-10-18
WO2002018358A1 (en) 2002-03-07
US20040034036A1 (en) 2004-02-19
PL361300A1 (en) 2004-10-04
AU2001284041A1 (en) 2002-03-13
BR0113650A (pt) 2004-02-10

Similar Documents

Publication Publication Date Title
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
MX242679B (es) Antranilamidas insecticidas.
FI20000004A0 (fi) Flavonoidilääke...
DE50114386D1 (de) Ng
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
NO20030868L (no) N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
CH695519A5 (de) Sperrstromthyristor.
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
DE60104232D1 (de) Schusseintragshilfsblasdüsen
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
ATA21172000A (de) Hackbrett
ATA17542000A (de) Hydraulikzylinder
ATA12252000A (de) Regensinkkasten
ATA11602000A (de) Sonnenstandsnachführungssystem
ATA19392000A (de) Kippflügelflugzeug
PT9613T (pt) Vysor 3 d
IS7299A (is) 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
UA3773S (uk) Шрифт
ITRC20000004V0 (it) Deodorante - souvenir "i calandreddhi"
ES1045935Y (es) Pupitre-silla mejorado.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application